Corona Serology Studies in IBD Patients (COSS!P)

Completed

• Conditions: IBD; inflammatory bowel disease; 10017969

• Registration Number: NL-OMON49552
• Lead Sponsor: OLVG

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 2400

Inclusion Criteria

Adult (older than 18 y) patients with inflammatory bowel disease, under care in
OLVG, undergoing blood sampling for routine care

Exclusion Criteria

Age below 18 years

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Serological status for SARS-Covid 2 at regular intervals defined by the moments<br /><br>of routine blood sampling for the monitoring of disease activity and medication<br /><br>use</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Short survey concerning symptoms that may be related to a SARS-Covid2 infection </p><br>